J0750 Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
Short descriptor: Hiv prep, ftc/tdf 200/300mg
Look up J0750 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J0750 is the HCPCS Level II code for Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Other carrier priced.
Classification & CMS Attributes
- Medicare Coverage
- Special coverage instructions apply (code D)
- Part B Pricing
- Other carrier priced (indicator 57)
- Type of Service
- Medical care
- Effective Date
- 2025-01-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis
- Route
- oral
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J0750 with the canonical source and edition:
J0750 — Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv). ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J0750
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J0750